Craft

Carl Zeiss Meditec

Stock Price

€59.5

2024-09-17

Market Capitalization

€5.6 B

2024-08-26

Revenue

€2.1 B

FY, 2023

Carl Zeiss Meditec Summary

Company Summary

Overview
Carl Zeiss Meditec is a company that provides medical technology solutions. It operates in two business segments: Ophthalmology and Microsurgery. The Ophthalmology segment is subdivided into two business units: the Ophthalmology systems unit covers a range of laser and diagnostic systems for ophthalmology, and the Surgical Ophthalmology unit combines the activities in the field of ophthalmic implants and disposables. The Microsurgery segment offers surgical microscopes and visualization solutions for ear, nose, and throat surgery.
Type
Public
Status
Active
Founded
2002
HQ
Jena, DE | view all locations
Sectors

Key People

  • Markus Weber

    Markus Weber, President and Chief Executive Officer

  • Justus Felix Wehmer

    Justus Felix Wehmer, Member of the Management Board and Chief Financial Officer

  • Markus Web

    Markus Web, Member of the Management Board and Chief Operating Officer

  • Eva-Maria Heine

    Eva-Maria Heine, Member of the Management Board and Chief Human Resources Officer

Operating MetricsView all

Order Backlog

€408.9M
38.3%

FY, 2023

Sales and Service Locations

60

FY, 2023

R&D Centers

30
3.4%

FY, 2023

LocationsView all

25 locations detected

  • Jena, TH HQ

    Germany

    Göschwitzer Str. 51-52

  • Dublin, CA

    United States

    5300 Central Pkwy

  • Macquarie Park, NSW

    Australia

    65 Epping Rd

  • Wien, Wien

    Austria

    Laxenburger Str. 2

  • Toronto, ON

    Canada

    45 Valleybrook Dr, North York

  • Shanghai, Shang Hai Shi

    China

    60 Mei Yue Road

and 19 others

Carl Zeiss Meditec Financials

Summary Financials

Revenue (H1, 2024)
€947.2M
Gross profit (H1, 2024)
€561.8M
Net income (H1, 2024)
€83.9M
Cash (H1, 2024)
€15.3M
EBIT (H1, 2024)
€108.2M
Enterprise value
$5.9B

Footer menu